Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum of 10.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in
the activity.
Objectives
After successful completion of this course, attendees should be able to:
- Identify at least two challenges related to the screening and surveillance of patients with colorectal cancer
- Evaluate at least two of the latest developments in the understanding of colorectal tumor biology
- Select the most appropriate adjuvant regimens for patients with colon and rectal cancer
- Describe a systematic continuum of care for patients with advanced disease, including selecting the most appropriate first- and second-line chemotherapy regimens
- Discuss supportive care issues in the management of patients with colorectal cancer, including chemotherapy-induced neurotoxicity and EGFR dermatologic toxicity
- Identify at least two promising new agents in the treatment of
colorectal cancer
- Describe and evaluate tests to identify at least three genes that may predict benefit of chemotherapy and likelihood of recurrence for
colon cancer
Who Should Attend
This educational activity is specifically designed for medical and radiation oncologists, gastroenterologists, colorectal surgeons, physicians enrolled in fellowship training programs in gastrointestinal oncology, and other healthcare professionals (gastroenterology and oncology nurses) in active clinical practice who wish to review and update their knowledge and management of colorectal cancer.
Friday, August 27, 2010
7:00 am
Breakfast and registration
8:00 am
Welcome and introduction
Session I: Patients at risk for colon cancer
8:10 am
Recognizing and managing patients with inherited colon cancer syndromes
8:30 am
Colon cancer screening - new molecular markers in stool and blood
8:50 am
Prevention strategies–the role of exercise, supplements, and diet
9:10 am
Follow up for patients with colon cancer - how often should you test?
9:30 am
The late effects of colon cancer therapy - the impact of fatty infiltration and chronic neuropathy
9:50 am
Patients at risk panel discussion
10:10 am
Break
Session II: Stage II colon cancer cases
10:30 am
The biology of microsatellite instability - who to test, how to test
10:50 am
Predictive/prognostic markers for colon cancer - are gene panel tests ready for prime time?
11:10 am
Surgical issues, node sampling - why the variability?
11:30 am
Chemotherapy for stage II colon cancer - how do we define high risk?
11:50 am
Stage II colon cancer panel discussion
12:10 pm
Lunch
Session III: Pathology - stage II, III, IV colon cancer cases
1:45 pm
Evaluating assay methodology
2:05 pm
Determining what to measure in whom
Session IV: Resectable metastatic–wildtype KRAS cases
2:25 pm
Front-line chemotherapy choice and management- how did combination chemotherapy become the standard?
2:45 pm
Timing of surgery and managing toxicity issues - do biologics play a role in neo-adjuvant therapy?
3:05 pm
MRI in colorectal cancer- what is the best method to assess liver resectablility?
3:25 pm
Resectable metastatic disease panel discussion
3:45 pm
Break
Session V: Non-resectable metastatic colon cancer
4:05 pm
Novel therapies on the horizon
4:25 pm
When is the optimum time to use EGFR antibodies?
4:45 pm
Is there a role for local therapies in liver dominant (not isolated) disease?
5:05 pm
Non-resectable metastatic disease panel discussion
5:15 pm
Closing remarks
5:20 pm
Adjourn
Saturday, August 28, 2010
7:00 am
Breakfast and registration
8:00 am
Introduction
Session VI: Comprehensive colorectal roundtable case presentation
8:10 am
Radiation oncologist
Surgical oncologist
Medical oncologist
Gastroenterologist
This panel will discuss a virtual patient with colon cancer, detailing differential management issues. A simultaneous, interactive webcast will be available for participants to view the activity and submit questions and cases over the internet.
9:30 am
Break
Session VII: Imaging–metastatic rectal cancer cases
9:45 am
PET in colorectal cancer
10:05 am
Endoscopic ultrasound in rectal cancer
10:25 am
MRI in rectal cancer
10:45 am
Rectal cancer panel discussion
Session VIII: A year in review from the GI world
11:05 am
An examination of major announcements in 2010 that will impact treatment of patients with gastrointestinal cancer including updates from The Annual Oncology Meeting, AACR, ESMO, World Congress on GI Cancer, and others
11:35 am
Closing remarks
11:50 am
Adjourn
To Register: You may register online by
August 19, 2010 at www.imedex.com, by calling Imedex at +1 (678) 242 0906, or by returning the registration form in this program by mail or fax. If you mail the form, please keep a copy for your records. Registration confirmations will be issued before the meeting.
To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.
$195 Discounted Physician
Payment received by June 29, 2010
$295 Regular Physician
Payment received by August 19, 2010
$395 Full/Onsite Physician
Payment received after August 19, 2010
$50 Group discount (physicians only)
Cannot be combined with any other discounts
$75 Nurses/Residents/Students
Proof of eligibility must accompany registration
The Registration and Information Desk at the The Westin New York at Times Square will be staffed:
Friday, August 27, 2010
7:00 am – 5:30 pm
Saturday, August 28, 2010
7:00 am – 12:00 pm
Group Discounts: Each one of multiple registrants from the same institute or practice will receive a $50 discount off the published registration fees, provided all registration forms and payments are received together. Only one discount will apply per physician. Discounts are not available for Nurse/Resident/Student rate.
Payment: To pre-register, registration and payment must be received no later than August 19, 2010. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.
Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.
Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than August 19, 2010. The amount of registration fees remitted, minus a $75 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds
will be made if notice is received after
August 19, 2010.
Imedex does not accept responsibility for covering travel, accommodation, or any other costs incurred by registrants in the rare event that this program should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda content is subject to change without notice.
The Westin New York at Times Square
270 West 43rd Street
New York, New York, 10036, USA
Tel: (212) 201-2700 Fax: (212) 201-2701
http://www.starwoodmeeting.com/Book/imedexoncology
This 45-story tower is one of New York City’s architectural masterpieces. Set on Times Square, visitors have instant access to the city’s various attractions. With the action of midtown Manhattan below and the subway moments away, The Westin New York at Times Square guests can experience all that New York has to offer. The hotel offers high speed internet access and a Westin workout gym with fantastic views. Our 863 spacious guest rooms and suites enable you to relax with stylish, soothing amenities. Rooms are designed with a clean and chic decor, featuring the Heavenly Bed and Heavenly Bath.
For the convenience of attendees, a limited number of rooms have been reserved until August 5, 2010 at a discounted rate of $239.00 single/double occupancy, plus tax, currently at 14.75% and $3.50 per person / per night occupancy tax. This rate is not guaranteed outside the conference dates or after August 5, 2010.
To reserve your room please contact the The Westin New York at Times Square reservations department at 1-866-837-4183 or visit the hotel’s website at http://www.starwoodmeeting.com/Book/imedexoncology. To receive the group rate, callers must identify themselves as being with the Imedex group. Reservation requests received after August 5, 2010 may not be guaranteed the group rate.
Dear Colleague,
It is with great pleasure and enthusiasm that we invite you to attend the 11th Annual Perspectives in Colorectal Cancer. As our focus for this meeting is on the latest advances and new insights for personalized care of your patients, we have titled the meeting this year “Challenging the Guidelines”.
From genetics to the systematic continuum of care for patients of advanced disease, and from the optimal use of standard therapies to expert perspectives on emerging agents, we will address the full spectrum of clinical management in sessions that integrate biology and medicine. Case studies will steer the curriculum, allowing us to explore when the guidelines do not sufficiently cover specific aspects of treating patients with colorectal cancer. Our intent is to provide clinicians the information they increasingly need to direct anti-cancer therapy based on the unique characteristics of each patient and their disease.
Our ultimate goal is to provide you with the information you need to optimize care of all your colorectal cancer patients. We hope you will join us this summer in New York!
Chairs: Richard M. Goldberg, MD
and John L. Marshall, MD
Organizer
Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2010 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
The following company has provided an restricted educational grant in support of this Conference:
BRONZE
Several options are available to companies interested in supporting this conference.
For more information, please contact Imedex at +1 (770) 751 7332, or by email at cme@imedex.com.
The following companies are exhibitors at this Conference:
Opportunities are available to companies interested in exhibiting at this conference.
For more information, please contact Cori Gunter at +1 (678) 242 0712, or by email at c.gunter@imedex.com.
